<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Professor Dr. Raimon Miralbell is the Director of the Radiotherapy Oncology Service of the Teknon Oncology Institute, Chief of the Radio-oncology Services for the University Hospitals of Geneva in Switzerland and Professor at the Faculty of Medicine of the University of Geneva.</p> <p>He has a Medical Doctor&rsquo;s degree from the University of Geneva. Since 1997 he has studied at renowned European and North American Centers, of which worth mentioning is the Royal Marsden Hospital in Sutton-Surrey in the United Kingdom and the City of Hope National Medical Centre in Duarte, California, in the United States. A Doctor and researcher for the proton therapy project from 1987 to 1989 at the Massachusetts General Hospital and for the Harvard Cyclotron Laboratory at Harvard University, Cambridge in Boston, Massachusetts, his main research areas are prostate cancer, breast cancer, high precision radiotherapy techniques and radio-biological mathematical models on the response of cancer to radiation. He is a member and founder of the European Scientific Institute (ESI) tied to the Centre Europ&eacute;en de Recherche Nucl&eacute;arie, CERN (European Organization for cancer research and treatment) where he develops and manages training programs and new radiotherapy technology research projects and he has been the President of the Swiss Proton Users Group. He has also been invited as a speaker at numerous national and international meetings.&nbsp;</p> <p>His main expertise and research domains in the field of radiation oncology are:&nbsp;</p> <ul> <li>Imaging for radiotherapy treatment planning of breast and prostate cancer</li> <li>Treatment precision optimization through image guided radiotherapy</li> <li>Biomathematical modeling of prostate cancer response to irradiation and fractionation sensitivity: ultra-hypofractionation as a dose escalation method.</li> <li>Biomathematical modeling for salvage radiotherapy after post-irradiation local failure for prostate cancer</li> <li>Stereotactic beam radiotherapy for prostate, gynecologic, ocular/orbital, and oligometastatic tumors</li> <li>Proton therapy</li> </ul> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Gaurav Kumar received primary medical education and core oncology training from India. After working as a consultant in oncology in India for many years he attained the Certificate of Equivalence for Specialist Registration (CESR) from the General Medical Council (GMC) in 2015. Since then he has been working as a Consultant Clinical Oncologist at The James Cook University Hospital, Middlesbrough. Dr. Kumar also has peripheral clinics at North Tees and Hartlepool Hospitals NHS Foundation Trust.</p> <p>With a special interest in lung and urological cancers including prostate and bladder cancer, he has vast experience in treating these conditions with radiotherapy, chemotherapy and immunotherapy. Besides this he has interests in targeted therapies like Stereotactic Ablative Radiotherapy (SABR/SBRT). With a key interest in clinical trials he has been a part of many national and international trials in both thoracic and urological malignancies. He has been involved in many national and international peer reviewed research article publications from time to time.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr Jason Lester is a senior Consultant Clinical Oncologist based in South Wales. He trained and qualified in United Medical and Dental Schools of Guy&rsquo;s &amp; St Thomas&rsquo;s in 1993. He completed his general medical training in London and the South East of England before moving to Wales in 1997. He joined Velindre Cancer Centre in 1997 and completed his Clinical Oncology training in 2003.</p> <p>Dr Lester was appointed as a consultant Oncologist in 2003, specialising in the management of lung (non-small cell, small cell, mesothelioma) and urological (prostate, kidney, bladder) cancers. His NHS practice is based in South East Wales, with clinics in The Royal Gwent Hospital Newport, University Hospital Llandough, Cardiff and Velindre Cancer Centre, Cardiff. He is an Associate Clinical Director at Velindre and Director of Stepping Stones, the Wales-based lung cancer charity.</p> <p>He is currently Deputy Clinical Director of Velindre Cancer Centre, and Chairman of the Rutherford Cancer Centre Local Medical Advisory Committee for Wales. He is also the Clinical Lead for the All Wales Prostate Cancer Brachytherapy Service.</p> <p>Dr Lester participates in a large number of clinical trials in both lung and urological cancer sites, and has published extensively in these fields. He is the lead investigator in the I-START trial, (dose escalated radiotherapy) and the SKOPOS trial, a vaccine trial in malignant pleural mesothelioma. He is responsible for prescribing and supervising the administration of radiotherapy, radioisotope treatment, cytotoxic chemotherapy and hormone therapy.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr Russell Banner is a Consultant Clinical Oncologist based in South Wales. His undergraduate training was at Christ&rsquo;s College, Cambridge and then at Guy&rsquo;s, Kings and St. Thomas&rsquo; Medical School in London, qualifying in 2002. He trained as a junior doctor in London and became convinced of a career in Clinical Oncology after working for 6 months in the Royal Marsden Hospital.</p> <p>He started his speciality training in Canterbury in 2007 and then transferred to complete his training in South Wales gaining Fellowship of the Royal College of Radiologists in 2010. He undertook an Advanced Radiotherapy Clinical Research Fellowship at Velindre Cancer Centre in 2011 and completed his MSc with the Institute of Cancer Research in London in 2013 researching Human Papilloma Virus specific T-cell immune responses before and after chemoradiotherapy for oropharyngeal cancer.</p> <p>Russell took up his post as a Consultant Clinical Oncologist in the South West Wales Cancer Centre in 2013. His specialist tumour sites are Head &amp; Neck and Gynaecological Cancers. He is enthusiastically research active with Principal Investigator roles in Swansea for a number of UK-wide randomised clinical research radiotherapy trials. He has developed an interest in Radiotherapy Quality Improvement in his role as Radiotherapy Lead in the South West Wales Cancer Centre.</p> <p>Russell is trained in the use of Proton Beam Therapy in Head &amp; Neck and Gynaecological Cancers and looks forward to developing the evidence base for the benefit of this treatment in these tumour sites.</p> <p>Russell was born in London, though his mother ensured that his first rugby shirt was Welsh! He has a love for Southern Africa having spent a year working there in the mid-1990&rsquo;s and returns whenever he gets the opportunity. He is now happily settled in South Wales with his wife and children.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Prof. Roger Taylor is a Consultant Clinical Oncologist specialising in the treatment of patients with brain tumours and lymphoma. Professor Taylor was born and educated in Swansea, and trained in Medicine at University College, Oxford and St Bartholomew&rsquo;s Hospital Medical College. His oncology training was at the Royal Marsden Hospital, Royal London Hospital and Western General Hospital, Edinburgh.</p> <p>He worked as a Consultant Clinical Oncologist in Leeds from 1987-2006, specialising mainly in the treatment of children with cancer. Professor Taylor returned to Wales in 2006, to work in the South West Wales Cancer Centre, Singleton Hospital, Swansea and the College of Medicine, Swansea University.</p> <p>Professor Taylor provides specialist advice on proton radiotherapy in Wales, and currently is undertaking research in this field. He is author of many papers on the treatment of children with cancer, particularly brain tumours.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr Ramkumar is a Consultant Clinical Oncologist specialising in non-surgical treatment of Head and Neck cancer, Skull Base Tumours and GI cancers since 2009 based in Southampton. He completed Oncology training in India in 1997 and further Clinical Oncology training in Wessex Clinical Oncology Training Scheme, UK in 2009.</p> <p>Dr Ramkumar held several leadership roles in Post Graduate Training (Training Programme Director, RCR College Tutor, RCR Speciality Training Board Member, RCR Curriculum Committee Member, National Recruitment Steering Group, RCR Faculty Board Member) technical Lead roles (IMRT Lead, IORT Lead, Clinical Governance Lead, SRS lead), Management roles (Clinical Leaders Forum Board Member-Genesis Care, UK, Medical Director-Proton Therapy UK) and National e-Proton Steering Group Member. He is Specialist Advisor for Quality Care Commission, Expert Reviewer for National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre (NETSCC), Reviewer for Journal of Clinical Oncology, Senate Member of Clinical Reference Group (CRG) for Complex Head &amp; Neck cancer &amp; National Cancer Peer Review Panel Member (Quality Surveillance Team).</p> <p>Dr Ramkumar is Principal Investigator for several national &amp; International Clinical Trials in Head &amp; Neck cancers. He is project Consultant for LLLT studies at University of Hong Kong. He had pioneered the implementation of Low Level Laser Therapy (LLLT) for treating cancer treatment related toxicities and Intraoperative Electron Radiotherapy (IOERT) for cancer treatment in UK.</p> <p>Dr Ramkumar is Senior Medical Advisor and Lead Clinician-Proton Therapy for Rutherford Cancer Centre South Wales. He has keen interest in improving cancer outcomes and reducing cancer treatment related toxicities.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Professor Peter Barrett-Lee is a Consultant Clinical Oncologist, Professor of Oncology in the School of Medicine at Cardiff University and lead specialist in breast cancer and skin cancer at Velindre NHS Trust and the University of Wales.</p> <p>Professor Peter Barrett-Lee was Medical Registrar at Mayday Hospital, Croydon and gained Membership of the Royal College of Physicians in 1985. He gained his Doctorate of Medicine Thesis in the laboratory of the Medical Breast unit at St George&rsquo;s Hospital, London under the supervision of Professor R Charles Coombes. He trained for 5 years in both radiotherapy and medical oncology at the Royal Marsden Hospital and obtained the Fellowship of the Royal College of Radiologists. He then worked at the Meyerstein Institute of Clinical Oncology at UCL Hospitals London on several clinical trials of new hormones and chemotherapy that have now become standard treatments.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr Hans van der Voet is a senior consultant clinical oncologist and radiotherapy lead at the James Cook University Hospital in Middlesbrough. He qualified at the University of Amsterdam Medical School in 1989 and started his radiotherapy training at The Netherlands Cancer Institute/Anthony van Leeuwenhoek Hospital in Amsterdam in 1990. He took a year out from training to do a clinical fellowship in bladder cancer at the Christie Hospital in Manchester from 1993. After completion of specialist training at the NCI/AvL in 1995, he returned to the Christie hospital as a senior registrar. In 1997 he took up a position as consultant clinical oncologist in Middlesbrough.</p> <p>Dr Hans van der Voet specialises and manages a busy practice in urological cancers, lower gastrointestinal cancer including anal cancer and sarcoma. He was instrumental in establishing image guided radiotherapy and subsequently intensity modulated radiotherapy in Middlesbrough. He has a fast experience in the treatment of prostate cancer including stereotactic radiotherapy.</p> <p>Dr Hans van der Voet also has an interest in providing radiotherapy for the treatment of early Dupuytren&rsquo;s disease and has been treating patients for this condition since 2013. Dr van der Voet is a member of the Northern Cancer Alliance Radiotherapy Expert Advisory Group.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Daniel Alejandro Mazal is the Technical Director and Head of Medical Physics at the Fundacion Quironsalud-Centro de Protontherapia Quironsalud.&nbsp;After obtaining initial experience in Argentina, he worked on high-precision techniques at Curie Institute in France developing original solutions for the use of detectors and providing multicentric European recommendations (eg Dynarad). He developed original apertures for small fields and micrometric immobilisation systems, that were used in clinics and also adopted by the industry (eg Arplay).</p> <p>He started the clinical program with doctors from Institut Curie and the public hospitals in Paris treating small tumors, metastases and arteriovenous malformations. In the 90&rsquo;s, Dr Mazal directed the conversion of an existing nuclear physics laboratory based on a 200MeV synchrocyclotron in Orsay into a clinical facility. Dr Mazal lead the process to install a clinical turn-key proton therapy system in a 50 million euros project, the largest for Curie Institut and also in radiation therapy in France at that time. As the head of the medical service of Institut Curie, he introduced the state-of-the-art radiation therapy systems in France (eg Tomotherapy) with a staff of more than 100 persons under his direction working in three clinical sites.</p> <p>Along with his clinical activities, Dr. Mazal has guided international students at various stages of their careers. His fields of interest are dosimetry, instrumentation, image guided radiation therapy, management of organ movements and adaptive radiation therapy, use of minibeams and &quot;Flash&quot; irradiations.</p> <p>Dr. Mazal has more than 150 research publications to his credit. He has organized scientific meetings and was invited to speak at various talks internationally.&nbsp;</p> Read More